Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes
More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)
Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
05/2003
05/28/2003EP1313710A1 Pyrazole derivatives and their use as protein kinase inhibitors
05/28/2003EP1313701A1 Phenoxybenzylamine derivatives as selective serotonin re-uptake inhibitors
05/28/2003EP1313463A1 Fatty acid analogues for the treatment of cancer
05/28/2003EP0941100B1 Pharmaceutical compositions containing lamivudine and zidovudine
05/28/2003EP0814789B1 Pharmaceutical compositions comprising monoamine oxidase b inhibitors
05/28/2003CN1420878A Compound with growth hormone releasing properties
05/28/2003CN1420767A Pharmaceutical formulation contg. tolterodine and its use
05/28/2003CN1420763A Orally administered controlled delivery system for once daily administration of ciprofloxacin
05/28/2003CN1109543C Pharmaceutical prepn. comprising eicosapentaenoic acid and/or stearidonic acid
05/27/2003US6569842 Method of preparing and use of prodrugs of betulinic acid derivatives
05/27/2003US6569443 Topical treatment or prevention of ocular infections
05/27/2003CA2332633C Method and system for color customizing cosmetic mass products
05/27/2003CA2032201C Sunscreen compositions
05/22/2003WO2003042177A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5)
05/22/2003WO2003041724A1 Use of a mixture of sodium hyaluronate and chondroitin sulfate for the treatment of osteoarthritis
05/22/2003WO2003041722A1 Use of specific dose of fondaparinux sodium for the treatment of acs
05/22/2003WO2003041647A2 Synthesis and purification of valacyclovir
05/22/2003WO2003011277A3 Methods to mobilize progenitor/stem cells
05/22/2003US20030096016 Methods of kidney transplantation utilizing developing nephric tissue
05/22/2003CA2649826A1 Synthesis and purification of valacyclovir
05/22/2003CA2465776A1 Use of specific dose of fondaparinux sodium for the treatment of acs
05/22/2003CA2464861A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5)
05/21/2003WO2004041156A2 Method for determining sensitivity to a bacteriophage
05/21/2003EP1312363A1 Methods of treatment and kits comprising a growth hormone secretagogue
05/21/2003EP1311679A2 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders
05/21/2003EP1311668A2 Compositions and methods for the diagnosis and treatment of tumor
05/21/2003EP1311488A1 Substituted imidazoles as tafia inhibitors
05/21/2003EP1311256A2 Use of derivatives of valproic acid amides and 2-valproenic acid amides for the treatment or prevention of pain and/or headache disorders
05/21/2003EP1147114B1 Novel aralkyl amines of spirofuropyridines useful in therapy
05/21/2003EP1142578B1 Method for producing an antitumoral agent and antitumoral agent thus obtained
05/21/2003EP1047668B1 Triazepinones, process for their preparation and their therapeutic application
05/21/2003EP0411031B1 THE HUMAN C3b/C4b RECEPTOR (CR1)
05/21/2003CN1419441A Fast dissolving orally consumable films containing an ion exchange resin as a taste masking agent
05/21/2003CN1418966A Resoldution method for racemic compound of nucleoside enantiomorph
05/21/2003CN1109108C Method for resolution of a racemic mixture of nucleoside enantioners
05/21/2003CN1108814C Process for manufacture of pharmaceutical composition containing polyethylene glycol protein conjugates
05/21/2003CN1108807C Chinese herbs extract and preparation method and use thereof
05/21/2003CA2474159A1 Method for determining sensitivity to a bacteriophage
05/20/2003US6566542 Such as 17-alpha-fluoro-11-beta-(4-(2-(1-piperidinyl) ethoxy) phenyl)-estra-1,3,5(10)-trien-3-ol for treatment of osteoporosis and cardiovascular protection; side effect reduction; provides alternative to estradiol
05/20/2003US6566526 Intermediates useful for the preparation of antihistaminic piperidine derivatives
05/20/2003US6565874 Polymeric delivery formulations of leuprolide with improved efficacy
05/20/2003US6565834 Skin composition
05/15/2003WO2003039476A2 Methods and compositions for treating hematological disorders using 232, 2059, 10630, 12848, 13875, 14395, 14618, 17692 or 58874
05/15/2003WO2003039459A2 Viral vector production methods and compositions
05/15/2003WO2003039458A2 TREATMENT OF HUMAN CANCER WITH ADENOVIRAL VECTOR EXPRESSING TNF-α
05/15/2003WO2003039442A2 Use of an extract from the vigna aconitifolia plant in a cosmetic and/or dermopharmaceutical composition
05/15/2003US20030093040 Method and device for the delivery of a substance
05/15/2003US20030092633 Preventing desensitization of receptors
05/15/2003US20030092617 Production of vascular endothelial cell growth factor and DNA enconding same
05/15/2003US20030091669 Mixture saponin, sugars and protein; solvent extraction, drying, sterilization; brain disorders, Alzheimer's disease
05/15/2003US20030091658 Herbal pharmaceutical composition for treatment of HIV/AIDS patients
05/15/2003US20030089369 Pressurised metered dose inhalers (MDI)
05/15/2003CA2466278A1 Rehydrating formulation
05/15/2003CA2465361A1 Treatment of human cancer with adenoviral vector expressing tnf-.alpha.
05/14/2003EP1310261A1 Use of the extract of Vigna aconitifolia in a cosmetic and/or dermopharmaceutical composition
05/14/2003EP1310259A2 Formulation comprising a biphosphonate and an absorption enhancing agent for the treatment of osteoporosis
05/14/2003EP1309691A2 Anti-tnf antibodies, compositions, methods and uses
05/14/2003EP1309607A2 Method for producing peptide salts, their use, and pharmaceutical preparations containing these peptide salts
05/14/2003EP1309605A1 Prodrugs of betulinic acid derivatives for the treatment of cancer and hiv
05/14/2003EP1309555A1 Process for making amlodipine maleate
05/14/2003EP1309547A1 Crystalline and pure modafinil, and process of preparing the same
05/14/2003EP1309332A2 Macrolide formulations for inhalation and methods of treatment of endobronchial infections
05/14/2003EP1309317A1 Pharmaceutical compositions comprising amlodipine maleate
05/14/2003EP1309308A2 Epilatory compositions
05/14/2003EP1140189B1 Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indications
05/14/2003EP1021194B1 New improved formulation for treatment of osteoporosis
05/14/2003CN1108152C Rapamycin formulations for oral administration
05/13/2003US6562978 N-(3-(4-(4-(Aminocarbonyl)benzyl)-1-piperidinyl)propyl)-N-(3, 4-dichlorophenyl)-1-(methylsulfonyl)-4-piperidinecarboxamide or a salt thereof for treatment of AIDS
05/13/2003US6562867 Halogenated 2-phenyl-1,2-ethanediol monocarbamate derivatives
05/13/2003US6562861 Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors
05/13/2003US6562363 Bioadhesive compositions and methods for topical administration of active agents
05/13/2003US6562336 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
05/13/2003CA2307048C Galenic preparation for prevention and treatment of hepatocarcinoma
05/08/2003WO2003037253A2 Methods for the treatment and diagnosis of tumorigenic and angiogenic disorders using 32616
05/08/2003WO2003011217A3 Grifola extracts and methods of use thereof
05/08/2003WO2001091763A9 Extracts from spermatophyte plants with antitumor activity
05/08/2003US20030087872 Fucosidase 32616 is differentially expressed in tumor and/or angiogenic tissue samples as compared to normal tissue samples
05/08/2003US20030087822 Parathyroid hormone antagonists and uses thereof
05/08/2003US20030087314 Immunogenic composition for use in the diagnosis of allergies in mammals
05/08/2003US20030087307 Compound for use in the prevention and treatment of respiratory and nervous system disorders
05/08/2003US20030086992 Anti-HSV agent for inhibiting replication of HSV-1 and HSV-2 and method of producing a substance having anti-HSV activity
05/08/2003US20030086987 Administering formulation containing salvianolic acid B for therapy of inflammatory injury to the cardiovascular system caused by oxidized low density lipoprotein
05/08/2003US20030086985 Method of treating diabetes using plant argyrolobium roseum extract, and a process for the isolation of extract from the said plant
05/08/2003US20030086984 Treating collected plant material with a solvent to extract a fraction having appetite suppressant activity, separating extraction solution from plant material, removing the solvent from extraction solution and recovering
05/08/2003US20030086904 Therapeutic regimen for treating cancer
05/08/2003US20030086903 Therapeutic regimen for treating cancer
05/08/2003US20030086900 Method of treatment using ligand-immunogen conjugates
05/08/2003US20030086867 Blood clot-targeted nanoparticles
05/07/2003EP1307436A1 Process for the preparation of baccatin iii derivatives
05/07/2003EP1200106B1 Composition containing extracts of butyrospermum parkii and the use as medicament or dietary supplement
05/07/2003EP0981527B1 Salt of naphthyridine carboxylic acid derivative
05/07/2003EP0971722B1 An aphrodisiac for application to the sexual organs
05/07/2003EP0812184B1 Nitric oxide synthase inhibitors
05/07/2003CN1416333A Oral compsn. comprising z'-hydroxypropiophenone
05/07/2003CN1415372A Medicament compsn. for curing acute pharyngitis and its preparation method
05/07/2003CN1415371A Medicament for curing colpitis mycotica and trichomonal vaginitis and its preparation method
05/07/2003CN1415370A Medicament for curing stomach-ache
05/07/2003CN1107503C Optically pure compoun as medicinal use
05/06/2003US6559312 Intermediates useful for the preparation of antihistaminic piperidine derivatives
05/06/2003US6559168 Thiazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes
1 ... 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 ... 295